← FDA Drug Approvals (Drugs@FDA)

DIAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2016-06-24

Drug application

FDA Application #

ANDA206477

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIAZEPAM

Generic name

DIAZEPAM ORAL

Active ingredients

DIAZEPAM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell Governmental & Specialty RX, LLC.

First approval

2016-06-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown